Promethazine Hydrochloride (Phenergan)
Is It Right for You?
A complete guide to Promethazine Hydrochloride (Phenergan) — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Promethazine Hydrochloride (Phenergan)?
Promethazine hydrochloride is a first-generation antihistamine belonging to the phenothiazine chemical class. It was first synthesised in the late 1940s and has been in continuous clinical use for over seven decades, making it one of the longest-established antihistamines available. It is marketed under the brand name Phenergan and is available both over the counter (for adults and children aged 2 years and over) and on prescription. It is supplied in 10 mg and 25 mg tablets and as a 5 mg/5 ml oral elixir.
Unlike second and third-generation antihistamines (cetirizine, loratadine, fexofenadine), promethazine readily crosses the blood-brain barrier due to its lipophilic nature. This results in significant central nervous system effects — most notably sedation — which are clinically utilised in its use as a sleep aid and anti-emetic, but which also account for the bulk of its adverse effect profile. Promethazine also possesses anticholinergic (antimuscarinic), antidopaminergic, and alpha-adrenergic blocking properties that contribute to both its therapeutic effects and side effects.
What Conditions Does Promethazine Treat?
Promethazine is prescribed for:
Promethazine is used for the symptomatic relief of allergic conditions including allergic rhinitis (hayfever), urticaria (hives), angioedema, contact dermatitis, and food or drug allergic reactions. Its H1 receptor antagonism reduces histamine-mediated symptoms including sneezing, rhinorrhoea, nasal itching, conjunctival itching, and urticarial whealing. However, because it causes significant drowsiness, it has been largely superseded by non-sedating second-generation antihistamines (cetirizine, loratadine) for first-line daytime allergy management. Promethazine retains a clinical role when sedation is a co-benefit — for example, in patients with severe urticaria disrupting sleep.
Promethazine is widely used as a short-term hypnotic agent. Its potent H1 antagonism in the CNS produces reliable sedation, and it is one of the most commonly used over-the-counter sleep aids in the UK, available as Phenergan Night Time 25 mg tablets. It is recommended only for short-term use (2 consecutive nights maximum on the OTC label; up to 7–10 nights on prescription) as tolerance to the sedative effect develops relatively quickly with repeated nightly use.
Promethazine has significant antiemetic properties derived from its antagonism of central H1 receptors in the chemoreceptor trigger zone (CTZ) and from its antidopaminergic (D2 receptor blocking) activity. It is used for nausea and vomiting from various causes including:
- Post-operative nausea and vomiting (PONV)
- Nausea associated with inner ear disorders (labyrinthitis, Ménière's disease)
- Chemotherapy-induced nausea (less commonly, as more specific agents are preferred)
- Nausea in pregnancy (off-label but widely practised — see cautions)
Promethazine is one of the most effective medications for the prevention and treatment of motion sickness. Its central H1 and muscarinic antagonism suppresses the vestibular input and CTZ signalling responsible for travel sickness. It should be taken 1 to 2 hours before travel begins for maximum prophylactic efficacy. It is particularly useful for long journeys where the sedative effect is acceptable or even advantageous.
Promethazine is used in hospital settings for preoperative sedation, adjunctive pain management (potentiating opioid analgesia), and paediatric procedural sedation. It is sometimes given intramuscularly in acute emergency settings for severe allergic reactions (adjunct to adrenaline), agitation, and refractory vomiting.
While Promethazine is effective for managing various conditions, it should be used cautiously in patients with respiratory issues or those taking other medications that may interact.
How Does Promethazine Work?
H1 Receptor Antagonism (Peripheral): Promethazine competitively blocks peripheral H1 histamine receptors on vascular endothelium, smooth muscle, and sensory nerve endings. This reduces vasodilation, capillary permeability, smooth muscle contraction, and the pruritic (itch) response to histamine — providing antiallergic and anti-urticarial effects.
H1 Receptor Antagonism (Central): Because promethazine is highly lipophilic, it crosses the blood-brain barrier readily and blocks central H1 receptors in the CNS. Histamine normally plays a wakefulness-promoting role in the CNS via the tuberomammillary nucleus. Blocking central H1 receptors suppresses this wakefulness signal, producing the pronounced sedation that characterises first-generation antihistamines.
Antiemetic Action: Promethazine blocks H1 receptors in the nucleus of the solitary tract and vestibular nucleus, reducing motion-related vestibulo-vomiting signals. Its D2 receptor antagonism in the chemoreceptor trigger zone (CTZ) additionally suppresses nausea from chemical stimuli (drugs, metabolic disturbances).
Anticholinergic (Antimuscarinic) Action: Blockade of muscarinic receptors reduces secretions (dry mouth, reduced gastrointestinal motility, urinary retention) and also contributes to antiemetic and motion sickness benefits (suppression of vestibular input through the vagal system).
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Tablets shoPromethazine Hydrochloride (Phenergan)uld be taken with food or milk to reduce gastrointestinal discomfort. The elixir should be measured carefully with the provided measuring spoon. For insomnia, take 20–30 minutes before intended sleep time.
Side Effects of Promethazine
Promethazine is generally well tolerated, but some side effects may occur.
- Drowsiness or sedation
- Dizziness
- Dry mouth
- Blurred vision
- Constipation
- Severe respiratory depression — slow or difficult breathing (higher risk in children and with high doses)
- Severe allergic reaction — swelling of face, lips, or throat, difficulty breathing
- Neuroleptic malignant syndrome (rare) — high fever, muscle rigidity, confusion
- Severe sedation or coma — especially with overdose or when combined with other sedatives
Patients should be informed about the risk of sedation and the importance of not driving or operating heavy machinery after taking Promethazine.
Drug Interactions
Inform your clinician about all medications you are taking, as some drugs can interact with Promethazine and affect its efficacy.
(e.g. opioids, benzodiazepines, alcohol) — May cause profound sedation, respiratory depression, coma, or death. Concomitant use should be avoided or closely monitored.
(e.g. Phenelzine, Tranylcypromine) — May prolong and intensify the anticholinergic and sedative effects of promethazine. Avoid concurrent use.
(e.g. Amiodarone, certain antipsychotics) — May increase the risk of QT prolongation and cardiac arrhythmias. Use cautiously in at-risk patients.
May increase sensitivity to sunlight; advise sun protection.
Important Warnings
Fatal cases of respiratory depression have been reported. This is an absolute contraindication. Promethazine should not be used in children under 2 years under any circumstances.
Promethazine causes significant sedation and psychomotor impairment. Do not drive, operate heavy machinery, or cycle while taking promethazine. The sedative effect may persist the following morning after a nighttime dose; morning driving should be avoided until the patient has assessed their own level of alertness.
Alcohol substantially potentiates the sedative and CNS depressant effects of promethazine. Do not drink alcohol while taking this medication.
In some children and elderly individuals, promethazine may cause paradoxical excitation — agitation, hyperactivity, nightmares, and irritability — rather than sedation. Parents should be counselled about this possibility before administration to children.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Promethazine FAQs
Promethazine is a first-generation antihistamine — the older class that readily enters the brain and causes significant sedation. Cetirizine and loratadine are second-generation antihistamines designed to have much lower CNS penetration, producing little to no drowsiness. For daytime allergy management, non-sedating antihistamines are generally preferred. Promethazine's sedative property is a disadvantage for daytime use but a clinical advantage when treating allergy-related sleep disturbance, motion sickness, or insomnia.
No. Phenergan is appropriate for short-term use only (up to 10 nights maximum on prescription). Tolerance to the sedative effect develops quickly with nightly use, typically within 1 to 2 weeks, reducing its efficacy. It is not recommended as a long-term solution for insomnia. Persistent insomnia warrants a full clinical assessment and consideration of cognitive behavioural therapy for insomnia (CBT-I), sleep hygiene interventions, and prescription hypnotics under appropriate medical supervision.
Promethazine has been used for nausea and vomiting in pregnancy for many years and has not been associated with an increased risk of major birth defects in large observational studies. It can be considered when dietary measures and first-line options have not provided adequate relief. It should be avoided in the first trimester where possible and near to the due date. Always discuss with a clinician before taking any medication during pregnancy.
Promethazine has a relatively long duration of action. A 25 mg dose taken at bedtime can cause residual sedation, drowsiness, and impaired performance the following morning — particularly in older patients or those with reduced hepatic metabolism. Patients should assess their own alertness before driving or operating machinery the morning after taking promethazine.
Promethazine is sometimes used off-label for acute situational anxiety, particularly in patients for whom benzodiazepines are inappropriate (history of dependence, respiratory disease), due to its sedative properties. This is not a licensed indication and should only be considered under clinician supervision. It is not appropriate as a treatment for generalised anxiety disorder or as a long-term anxiolytic.